Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
TLPH Stock Forecast 2025-2026
$1.25
Current Price
$58.26M
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to TLPH Price Targets
+180.0%
To High Target of $3.50
+160.0%
To Median Target of $3.25
+140.0%
To Low Target of $3.00
TLPH Price Momentum
-0.8%
1 Week Change
-3.1%
1 Month Change
+78.6%
1 Year Change
+140.4%
Year-to-Date Change
-20.4%
From 52W High of $1.57
+228.9%
From 52W Low of $0.38
📊 TOP ANALYST CALLS
Did TLPH Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if AcelRx is one of their latest high-conviction picks.
Latest TLPH Stock Price Targets & Analyst Predictions
Based on our analysis of 3 Wall Street analysts, TLPH has a bullish consensus with a median price target of $3.25 (ranging from $3.00 to $3.50). The overall analyst rating is N/A (N/A/10). Currently trading at $1.25, the median forecast implies a 160.0% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Jason McCarthy at Maxim Group, suggesting a 140.0% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
TLPH Analyst Ratings
2
Buy
0
Hold
0
Sell
TLPH Price Target Range
Low
$3.00
Average
$3.25
High
$3.50
Current: $1.25
Latest TLPH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for TLPH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 1, 2025 | HC Wainwright & Co. | Ed Arce | Buy | Reiterates | $6.00 |
| Jan 21, 2025 | HC Wainwright & Co. | Ed Arce | Buy | Reiterates | $6.00 |
| Aug 16, 2024 | HC Wainwright & Co. | Ed Arce | Buy | Reiterates | $6.00 |
| May 15, 2024 | HC Wainwright & Co. | Ed Arce | Buy | Reiterates | $6.00 |
| May 6, 2024 | Maxim Group | Jason McCarthy | Buy | Initiates | $3.00 |
| Mar 7, 2024 | HC Wainwright & Co. | Ed Arce | Buy | Reiterates | $6.00 |
| Jan 22, 2024 | HC Wainwright & Co. | Ed Arce | Buy | Maintains | $6.00 |
| Dec 7, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Oct 2, 2023 | Alliance Global Partners | Buy | Initiates | $N/A | |
| Sep 25, 2023 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Aug 18, 2023 | HC Wainwright & Co. | Buy | Upgrade | $N/A |
Talphera Inc. (TLPH) Competitors
The following stocks are similar to AcelRx based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Talphera Inc. (TLPH) Financial Data
Talphera Inc. has a market capitalization of $58.26M with a P/E ratio of -2.5x. The company generates $28,000 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of -342,200.0% and return on equity of -86.5%.
Valuation Metrics
Market Cap
$58.26M
Enterprise Value
$42.54M
P/E Ratio
-2.5x
PEG Ratio
0.2x
Price/Sales
2,047.5x
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
-342,200.0%
Net Margin
0.0%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+36.6%
Current Ratio
6.8x
Debt/Equity
33.9x
ROE
-86.5%
ROA
-31.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Talphera Inc. (TLPH) Business Model
About Talphera Inc.
What They Do
Provides renewable energy solutions through wind and solar.
Business Model
Talphera Inc. generates revenue by designing, developing, and deploying wind and solar power technologies for both commercial and residential markets. The company focuses on scalable energy systems and innovative energy efficiency and storage solutions, which contribute to its profitability through project contracts and infrastructure support.
Additional Information
Recognized as a key player in the renewable energy sector, Talphera Inc. is committed to supporting the global transition to sustainable energy. The company's efforts in modernizing energy grids further enhance its role in promoting environmental sustainability and economic growth.
Company Information
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
13
CEO
Mr. Vincent J. Angotti
Country
United States
IPO Year
2011
Website
talphera.comTalphera Inc. (TLPH) Latest News & Analysis
Latest News
Quick Summary
Talphera, Inc. (TLPH) will hold its Q3 2025 earnings call on November 12, 2025, at 4:30 PM EST. The call will feature key executives and is accessible via their website.
Why It Matters
Talphera's Q3 earnings call will provide insights into financial performance and strategy, impacting investor sentiment and stock valuation. Key executives will present, highlighting potential growth.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Talphera, Inc. closed a $17 million financing round, has $21.3 million in cash as of September 30, 2025, and expects funding to last until potential PMA approval in late 2026.
Why It Matters
Talphera's $17 million financing and sufficient cash to support PMA approval timelines indicate strong financial health and progress in clinical trials, positively impacting investor confidence.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Talphera, Inc. (Nasdaq: TLPH) will release its Q3 2025 financial results on November 12, 2025, after market close, followed by a live webcast and conference call at 4:30 p.m.
Why It Matters
Talphera's upcoming financial results and conference call may influence stock performance, providing insights into its growth, profitability, and future strategies impacting investor sentiment.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Talphera, Inc. has appointed Joe Todisco, CEO of CorMedix Inc., to its Board of Directors, enhancing its leadership in specialty pharmaceuticals.
Why It Matters
Talphera's addition of Joe Todisco, an experienced CEO, to its Board could enhance strategic direction and credibility, potentially boosting investor confidence and stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
CorMedix Inc. has invested $5 million in Talphera, acquiring 9,090,909 shares at $0.55 each as part of Talphera's private placement financing.
Why It Matters
CorMedix's investment in Talphera signals confidence in Talphera's potential and may influence market perceptions, impacting both companies' stock valuations and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market
3 months ago
Quick Summary
CorMedix is leading a $17 million investment in Talphera, with potential for an additional $12 million based on clinical study results, aimed at supporting a Niyad PMA approval by 2026.
Why It Matters
CorMedix's strategic investment in Talphera signals confidence in Talphera's pipeline and funding for clinical development, potentially boosting investor sentiment and stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About TLPH Stock
What is Talphera Inc.'s (TLPH) stock forecast for 2026?
Based on our analysis of 3 Wall Street analysts, Talphera Inc. (TLPH) has a median price target of $3.25. The highest price target is $3.50 and the lowest is $3.00.
Is TLPH stock a good investment in 2026?
According to current analyst ratings, TLPH has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.25. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for TLPH stock?
Wall Street analysts predict TLPH stock could reach $3.25 in the next 12 months. This represents a 160.0% increase from the current price of $1.25. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Talphera Inc.'s business model?
Talphera Inc. generates revenue by designing, developing, and deploying wind and solar power technologies for both commercial and residential markets. The company focuses on scalable energy systems and innovative energy efficiency and storage solutions, which contribute to its profitability through project contracts and infrastructure support.
What is the highest forecasted price for TLPH Talphera Inc.?
The highest price target for TLPH is $3.50 from at , which represents a 180.0% increase from the current price of $1.25.
What is the lowest forecasted price for TLPH Talphera Inc.?
The lowest price target for TLPH is $3.00 from Jason McCarthy at Maxim Group, which represents a 140.0% increase from the current price of $1.25.
What is the overall TLPH consensus from analysts for Talphera Inc.?
The overall analyst consensus for TLPH is bullish. Out of 3 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $3.25.
How accurate are TLPH stock price projections?
Stock price projections, including those for Talphera Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: December 11, 2025 4:20 AM UTC